Novo Nordisk's pricing procedures inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of cost gouging, declaring the stark contrast between U.S. prices and those in Europe and copyright.California biotech behemoth Amgen ditched strategies for an experimental weight loss tablet in May well